Deaths Waiting For Lung Donation Have Dropped Under New Guidelines
By Dennis Thompson HealthDay Reporter
WEDNESDAY, May 21, 2025 — New guidelines for allocating donated lungs are saving more lives, a new study says.
By prioritizing medical urgency, the guidelines caused a dramatic decline in the number of people who die waiting for a lung transplant, researchers reported Sunday at the American Thoracic Society’s international conference in San Francisco.
Patients are now three times less likely to die on the waitlist than before 2017, when a lawsuit kicked off a rethinking of the way donated lungs were allocated, researchers say.
The sickest patients on the waitlist saw the greatest benefit, researchers added.
“We always want to make sure that any time we make a change to the allocation system that we’re improving outcomes, especially for our sickest patients,” lead researcher Dr. Mary Raddawi, a second-year pulmonary and critical care fellow at Columbia University Irving Medical Center, said in a news release. “This provides confirmation that we’re on the right track.”
Prior to 2017, donor lungs were handed out based on geographical proximity, meaning that people living near the donor received priority access. The lawsuit caused the allocation radius to be expanded to a wider area, so the organs were available to more people.
Then in 2023, the United Network for Organ Sharing implemented a new Composite Allocation Score that prioritized a person’s medical urgency along with other health factors in choosing who gets donor lungs.
About 11% of patients died or were delisted while waiting for a transplant prior to 2017, but that declined to about 8% after proximity was expanded and dropped to 4% after the new guidelines were implemented, results show.
“When you think about the fact that now we’re focusing on many different factors, including medical urgency, it makes sense that the waitlist mortality would go down for our sicker patients — but it is nice to see the actual numbers,” Raddawi said.
The results show how important it is for doctors to advocate for their sickest patients, to make sure their medical urgency is reflected in their score, Raddawi said.
“We’re seeing that it really does make a difference for them,” she said.
The team next plans to look at the outcomes in greater detail, to see if certain factors considered in the donation scoring are linked to better outcomes than others.
Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-22 00:00
Read more

- Exercise, Rehab Services Can Be Integrated Into Breast Cancer Care
- Screen Time in Bed Linked to Poorer Sleep Among Young Adults
- FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
- Hypertensive Disorders of Pregnancy Adversely Affect Preemie Neurodevelopment
- Medetomidine, a Pet Sedative, Spreads in U.S. Illegal Drug Supply
- BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions